Cargando…

Transcriptional profiling reveals intrinsic mRNA alterations in multipotent mesenchymal stromal cells isolated from bone marrow of newly-diagnosed type 1 diabetes patients

BACKGROUND: Bone marrow multipotent mesenchymal stromal cells (MSCs) are a diverse subset of precursors that contribute to the homeostasis of the hematopoietic niche. MSCs can be isolated and expanded in vitro and have unique immunomodulatory and regenerative properties that make them attractive for...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Lima, Kalil A., de Oliveira, Gislane L. V., Yaochite, Juliana N. U., Pinheiro, Daniel G., de Azevedo, Júlia T. C., Silva Jr, Wilson Araujo, Covas, Dimas T., Couri, Carlos E. B., Simões, Belinda P., Voltarelli, Julio C., Oliveira, Maria C., Malmegrim, Kelen C. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942931/ https://www.ncbi.nlm.nih.gov/pubmed/27406064 http://dx.doi.org/10.1186/s13287-016-0351-y

Ejemplares similares

Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties
por: Yaochite, Juliana Navarro Ueda, et al.
Publicado: (2016)

Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice
por: Yaochite, Juliana Navarro Ueda, et al.
Publicado: (2015)

Correction to: Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies
por: Noronha, Nádia de Cássia, et al.
Publicado: (2019)

Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies
por: Noronha NC, Nádia de Cássia, et al.
Publicado: (2019)

New Horizons in the Treatment of Type 1 Diabetes: More Intense Immunosuppression and Beta Cell Replacement
por: Couri, Carlos E. B., et al.
Publicado: (2018)

Immunological Balance Is Associated with Clinical Outcome after Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
por: Malmegrim, Kelen C. R., et al.
Publicado: (2017)

Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19
por: Rocha, José Lucas Martins, et al.
Publicado: (2020)

Stem cell therapy for diabetes mellitus
por: Voltarelli, Júlio C, et al.
Publicado: (2011)

Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: From Mechanistic Insights to Biomarkers
por: Malmegrim, Kelen Cristina Ribeiro, et al.
Publicado: (2018)

Emerging Role of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Pathogenesis of Haematological Malignancies
por: Cominal, Juçara Gastaldi, et al.
Publicado: (2019)

Mesenchymal stem cells promote the sustained expression of CD69 on activated T lymphocytes: roles of canonical and non-canonical NF-κB signalling
por: Saldanha-Araujo, Felipe, et al.
Publicado: (2012)

Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy
por: Santana-Gonçalves, Maynara, et al.
Publicado: (2022)

Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients
por: Zanin-Silva, Djúlio C., et al.
Publicado: (2022)

Stem cell transplantation for type 1 diabetes mellitus
por: Voltarelli, Júlio C, et al.
Publicado: (2009)

Genes related to antiviral activity are differentially expressed in CD4(+) T cell in HAM/TSP patients
por: Pinto, Mariana T, et al.
Publicado: (2014)

Differences in the intrinsic chondrogenic potential of human mesenchymal stromal cells and iPSC‐derived multipotent cells
por: Xiang, Shiqi, et al.
Publicado: (2022)

CD3e expression in HTLV-1-infected individuals is associated with proviral load and Tax expression
por: Pinto, Mariana Tomazini, et al.
Publicado: (2011)

Metabolic and Pancreatic Effects of Bone Marrow Mesenchymal Stem Cells Transplantation in Mice Fed High-Fat Diet
por: Bueno, Patricia de Godoy, et al.
Publicado: (2015)

Identification of a Candidate Proteomic Signature to Discriminate Multipotent and Non-Multipotent Stromal Cells
por: Rosu-Myles, Michael, et al.
Publicado: (2012)

Editorial: Immune Profile After Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: Where Do We Stand?
por: Malmegrim, Kelen Cristina Ribeiro, et al.
Publicado: (2020)

Meniscus Regeneration With Multipotent Stromal Cell Therapies
por: Zhou, Yun-Feng, et al.
Publicado: (2022)

Bone Marrow Soluble Mediator Signatures of Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
por: Cominal, Juçara Gastaldi, et al.
Publicado: (2021)

Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies
por: Picanço-Castro, Virgínia, et al.
Publicado: (2020)

Reconstitution of the immune system and clinical correlates after stem cell transplantation for systemic sclerosis
por: Kawashima-Vasconcelos, Marianna Y., et al.
Publicado: (2022)

Long-Term Effects of Allogeneic Hematopoietic Stem Cell Transplantation on Systemic Inflammation in Sickle Cell Disease Patients
por: de Azevedo, Júlia Teixeira Cottas, et al.
Publicado: (2021)

Regulation of Immunity via Multipotent Mesenchymal Stromal Cells
por: Rubtsov, Y. P., et al.
Publicado: (2012)

Adult multipotent stromal cell cryopreservation: Pluses and pitfalls
por: Duan, Wei, et al.
Publicado: (2017)

Editorial: Multipotent stromal cells and microenvironment of the tissue healing
por: Lotfy, Ahmed, et al.
Publicado: (2023)

Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials
por: Couri, Carlos Eduardo Barra, et al.
Publicado: (2009)

Scalable Production of Equine Platelet Lysate for Multipotent Mesenchymal Stromal Cell Culture
por: Hagen, A., et al.
Publicado: (2021)

Mobilizing hematopoietic progenitor cells in donors with sickle cell trait is safe
por: De Santis, Gil Cunha, et al.
Publicado: (2019)

Microvascular Complications in Type 1 Diabetes: A Comparative Analysis of Patients Treated with Autologous Nonmyeloablative Hematopoietic Stem-Cell Transplantation and Conventional Medical Therapy
por: Penaforte-Saboia, Jaquellyne G., et al.
Publicado: (2017)

Cytoplasmic-targeted parvalbumin blocks the proliferation of multipotent mesenchymal stromal cells in prophase
por: Melo, Carolina Soares Barros, et al.
Publicado: (2013)

Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients
por: Jarduli‐Maciel, Luciana Ribeiro, et al.
Publicado: (2022)

Multipotent Mesenchymal Stromal Cells: Possible Culprits in Solid Tumors?
por: Johann, Pascal David, et al.
Publicado: (2015)

Multipotent Stromal Cells and Viral Interaction: Current Implications for Therapy
por: Taechangam, Nopmanee, et al.
Publicado: (2021)

GPCRs in the regulation of the functional activity of multipotent mesenchymal stromal cells
por: Chechekhin, Vadim I., et al.
Publicado: (2022)

Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo
por: Silvestre, Renata Nacasaki, et al.
Publicado: (2023)

Characterization and Comparison of Canine Multipotent Stromal Cells Derived from Liver and Bone Marrow
por: Malagola, Ermanno, et al.
Publicado: (2016)

Ex vivo evaluation of intravitreal mesenchymal stromal cell viability using bioluminescence imaging
por: Vilela, Carolina Assis P., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m5tpsqa6ql5tv7pcu46jhq96cf